First Report on the Effects of Lisaftoclax (APG-2575) in Combination with Novel Therapeutic Regimens in Patients with Relapsed or Refractory Multiple Myeloma (R/R MM) or Immunoglobulin Light-Chain (Amyloid Light-Chain [AL]) Amyloidosis-MedSci.cn

First Report on the Effects of Lisaftoclax (APG-2575) in Combination with Novel Therapeutic Regimens in Patients with Relapsed or Refractory Multiple Myeloma (R/R MM) or Immunoglobulin Light-Chain (Amyloid Light-Chain [AL]) Amyloidosis

Ailawadhi, S; Chanan-Khan, AA; Yannakou, CK; Gibbs, S; Khouri, J; Chen, Z; Guo, HS; Li, MY; Ahmad, M; Wang, CL; Yang, DJ; Zhai, YF

BLOOD, 2023; 142 ():

科室
- - 订阅+
  - 更多科室
工具
服务